Jim Reid

Board Member
Chairman & CEO of Sistemic Ltd

Jim has worked in the life sciences sector for the past 40 years, holding senior roles within a number of the sectors leading companies including Axis-Shield PLC, Chiron S.A, Hoffman la Roche and Trinity Biotech Inc.

Since 2000, he has managed ChimaeraBio, a specialist life sciences investment fund which he founded with Karen Reid and has been involved with a number of Scotland’s more successful life science companies including Haptogen (acquired by Wyeth), Qnostics (acquired by BBI plc) and D3 Technologies (acquired by Renishaw plc). Jim was also Chairman at Lumora on its very successful exit in 2015. He continues to be a Board Director of a number of Life Science companies, the Scottish Life Science Association and the Mercia Fund Investment Board.